Digital Health UK

UK Femtech Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

UK Femtech Market Industry Trends and Forecast to 2034: Segmented by (Type, Product, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

UK · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $847.3 Mn Placeholder estimate
Estimate 2025 $952.3 Mn 2.6% of the global market
Projected 2034 $2.73 Bn 186.3% Adds $1.77 Bn over 9 forecast years
CAGR 2025–2034 12.4% Faster than 45% of 100 Digital Health markets here
Key players 6 Companies profiled
  • UK is 2.62% of the global market.
  • In Europe, the largest is Germany at $1.15 Bn.
  • Fastest growing: Italy at 13.8% a year.
  • UK ranks 3rd of 6 by size in Europe.

Market size projection

UK

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$1.77 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Femtech Market market size by year, UK
YearMarket sizeChange that yearSince 2025
2024 (estimate) $847.3 Mn — —
2025 (base) $952.3 Mn +$105.1 Mn —
2026 (forecast) $1.07 Bn +$118.1 Mn +12.4%
2027 (forecast) $1.20 Bn +$132.7 Mn +26.3%
2028 (forecast) $1.35 Bn +$149.2 Mn +42%
2029 (forecast) $1.52 Bn +$167.7 Mn +59.6%
2030 (forecast) $1.71 Bn +$188.5 Mn +79.4%
2031 (forecast) $1.92 Bn +$211.9 Mn +101.6%
2032 (forecast) $2.16 Bn +$238.1 Mn +126.7%
2033 (forecast) $2.43 Bn +$267.7 Mn +154.8%
2034 (forecast) $2.73 Bn +$300.8 Mn +186.3%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

UK Femtech Market Analysis at a glance
Market size, 2025$952.3 Mn placeholder estimate
Forecast, 2034$2.73 Bn placeholder estimate
Growth (CAGR), 2025–203412.4% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsType, product and end user (see all)
Key playersFlo Health, Clue (BioWink), Maven Clinic, Elvie (Chiaro), Natural Cycles and 1 more (see all)
Regulator in the UKMHRASource: Medicines and Healthcare products Regulatory Agency. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The UK Femtech Market Analysis Executive Summary

Femtech covers apps, devices and services built for women's health, from period tracking to fertility, pregnancy, menopause and pelvic health.

Key segments of the femtech market include type (Period and Fertility Tracking, Pregnancy and Nursing Care and Pelvic Health) and product (Apps, Wearables and Connected Devices).

Bar chart: UK Femtech market size, 2024–2034, placeholder estimates. $847.3 Mn in 2024, $952.3 Mn in 2025 and $2.73 Bn in 2034, 12.4% CAGR.
UK Femtech market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

UK Femtech Market Dynamics

Market Growth Drivers

Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the femtech market. New products designed around women's biology and digital care are improving access.

Opportunity

Femtech, personalised care and new treatments for under-served conditions open strong growth for the femtech market, especially as employers and payers add women's health benefits.

Market Restraints

Under-diagnosis, stigma around some conditions, limited insurance coverage and a long history of under-research in women's health hold back the femtech market.

Competitive Landscape for Femtech Market in UK

The femtech market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Femtech Market in UK

Femtech in the UK: rules and payment

Software that works as a medical device is regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) in the same way as other medical devices.⁠[1] The NHS gives care that is free at the point of use; in England, NICE advises which medicines and treatments the NHS should fund.⁠[2]

Policy changes and Reimbursement scenario

Rules on software as a medical device, data privacy (such as HIPAA and GDPR) and telehealth reimbursement shape the femtech market. Government digital health programs in UK are speeding up adoption.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Femtech right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Femtech in context

The UK compared

  • Health spending per person: 5,860 US$ per person (2024). World: 1,317 US$ per person (2023). 2nd highest of the 6 countries we cover in Europe.[1]
  • Doctors: 3.30 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). 5th highest of the 6 countries we cover in Europe.[2]
  • People aged 65 and over: 19.7% of people (2025). World: 10.4% of people (2025). 5th highest of the 6 countries we cover in Europe.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 17 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Femtech market in the UK?
Placeholder estimate: about $952.3 Mn in 2025, rising to about $2.73 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Femtech market in the UK growing?
Placeholder estimate: about 12.4% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Femtech market report cover?
The report splits the market by type (Period and Fertility Tracking, Pregnancy and Nursing Care, Pelvic Health, Menopause Care and more), product (Apps, Wearables, Connected Devices, Services) and end user (Healthcare Providers, Patients, Payers, Pharmaceutical Companies).
Who are the key players in the Femtech market?
Key players include Flo Health, Clue (BioWink), Maven Clinic, Elvie (Chiaro), Natural Cycles and Oura.
What is driving the Femtech market?
Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the femtech market. New products designed around women's biology and digital care are improving access.
Who regulates Femtech in the UK?
Software that works as a medical device is regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) in the same way as other medical devices. Source: Medicines and Healthcare products Regulatory Agency. Checked 14 Nov 2026.
How is healthcare paid for in the UK?
The NHS gives care that is free at the point of use; in England, NICE advises which medicines and treatments the NHS should fund. Source: National Institute for Health and Care Excellence. Checked 14 Nov 2026.
How much research is published on Femtech?
PubMed lists 68 papers on Femtech added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Digital Health reports in UK

See all

Related on women's health and digital health

See the topic